ADIPOQ and metabolic dysfunction-associated steatohepatitis: They also had lower adiponectin levels compared to overweight men without steatosis with comparable visceral adiposity, suggesting that nonalcoholic steatohepatitis may be a factor for a more atherogenic risk profile besides its contribution to visceral adiposity [31].